Enter Martha Stewart with some expert advice, and now we have a game-changing solution: terry cloth towels. The Martha Moments Instagram account, which is a treasure trove of domestic tips and ...

Martha Minow, the new Chair of GBH’s Board of Trustees, grew up in the 1960s and never thought she would care so much about institutions. But she came to realize that the creation and nurturing of ...

This year, I have ranked the top 320 draft prospects. Let’s dive in. 2025 NFL Mock Draft: Pats go Tetairoa McMillan, Shedeur Sanders falls out of Round 1 if Connor Rogers were GM A Division of ...

Here's what you need to know about presumptive No. 1 draft pick Cam Ward. Another edition of 'Mock Draft Monday' rolls onto the pod feed as ESPN's Jordan Reid joins Matt Harmon to share his five ...

A goodwill invitation to the Livingstone Range School Division to present at a Town of Claresholm council meeting will result in a new committee to open and improve dialogue. Local school ...

Abstract and poster presentation details are below: Title: “Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib, in combination with encorafenib and cetuximab in patients with ...

This “trial-in-progress” presentation will focus on the design of the ongoing expansion portion of Mersana’s Phase 1 clinical trial of Emi-Le that is actively enrolling patients with triple ...

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI's pathology universal ...

Updated data from the Phase 1b trial of IMA203 in patients with metastatic melanoma with substantially longer follow-up compared to the last presentation in October 2024, and including data from ...

This "trial-in-progress” presentation will focus on the design of the ongoing expansion portion of Mersana's Phase 1 clinical trial of Emi-Le that is actively enrolling patients with triple negative ...

For more and to view the abstract, visit the AACR Annual Meeting website. As previously announced, on December 11, 2024, TuHURA entered into a definitive agreement with Kineta, Inc. (OTC Pink ...

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...